FibroGen - FGEN Operating Profitability

Corporate company logo of fibrogen.com (FGEN)

The change in the operating margin of FibroGen, Inc. (FGEN) demonstrates the impact of risks associated with failed new drug trials and patent disputes. Revenue stability is supported by the sale of treatments for fibrosis and anemia. However, -458.60 reflects the current level of the metric amid a cash deficit that forced management to reduce headcount and implement restructuring to preserve capital.

FGEN: fibrogen.com Operating Profitability Margin 07/04/2022 - 01/08/2026

Analytical breakdowns for FibroGen (FGEN)

- price and consensus price forecast:
Fundamental company valuation:FibroGen Corporation, FGEN
Core merchandise of fibrogen.com

Operating margin reflects cost management efficiency, expressing the share of operating profit in total revenue before financial expenses and taxes. By analyzing operating margin fluctuations, an investor assesses the internal resilience of FibroGen, Inc. (FGEN), which is supported by a stable climate in the US and the humanitarian status of the healthcare sector, minimizing the impact of geopolitical risks on business profitability.

Competitor analysis

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.